What Does a U.S. Crystal Patent Actually Bring to UTHPEAK™ NMNH?

Overview


EFFEPHARM LTD

Visit Booth #5365 at SupplySide Global 2026! EffePharm is bringing UTHPEAK™ NMNH to the show. It has secured a U.S. patent on the crystalline form of reduced NMNH calcium salt.

For our partners, that patented crystal form means superior stability at room temperature (25°C) with no cold chain required, high and consistent purity, longer shelf life for finished products, and real market exclusivity. Clinical data shows UTHPEAK™ NMNH boosts NAD+ levels by 3x and reduces biological age by 5 years.

Download our product brochure to explore the key advantages of UTHPEAK™, including anti-aging efficacy and memory improvement.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

The Global Regulatory Advantage Behind UTHEVER® NMN

The Global Regulatory Advantage Behind UTHEVER® NMN

Paid for by Effepharm Ltd

White Paper

Regulatory uncertainty remains one of the biggest challenges for NMN brands. Choosing the wrong ingredient could lead to compliance risks & market restrictions.

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.